ArticleOncoTargets and therapy2024

Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series.

Kaoruko Shimbu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.